Genetic Mutations in Parkinson's Disease Patients from Portugal
Author Information
Author(s): Bras Jose, Guerreiro Rita, Ribeiro Maria, Morgadinho Ana, Januario Cristina, Dias Margarida, Calado Ana, Semedo Cristina, Oliveira Catarina, Hardy John, Singleton Andrew
Primary Institution: Center for Neurosciences and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
Hypothesis
Are there mutations in the genes SNCA, PRKN, PINK1, and LRRK2 among Parkinson's disease patients in Portugal?
Conclusion
Mutations are common in Portuguese patients with Parkinson's disease, which has implications for genetic diagnosis and counseling.
Supporting Evidence
- The LRRK2 c.6055G > A; p.G2019S mutation has one of the highest frequencies in Europe among Portuguese patients.
- Seven patients showed pathogenic mutations in PRKN, and heterozygosity for LRRK2 was also observed.
- The study included both early-onset and late-onset familial Parkinson's disease patients.
Takeaway
This study looked at people in Portugal with Parkinson's disease to see if they had certain gene mutations, and many did.
Methodology
The study screened 66 early-onset and late-onset familial Parkinson's disease patients for mutations in SNCA, PRKN, PINK1, and LRRK2.
Limitations
A significant proportion of mutations might remain undetected due to the size and complexity of the PRKN gene.
Participant Demographics
Patients were primarily Caucasian and of apparent Portuguese ancestry, with a mean age of 60.1 years at collection.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website